UNSPSC 51162712: Fudosteine

This classification denotes a mucolytic agent with the molecular formula C6H13NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UR9VPI71PT, chemically known as l-cysteine, s-(3-hydroxypropyl)- but more generally known as fudosteine, which bears US NIH Compound Identifier 134669. European Medicines Agency schedules Fudosteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07825MIG.

UNSPSC 51162712 Fudosteine is a Commodity code that, based on recent state and local solicitations, encompasses pharmaceutical products including naloxone, generic multi-source pharmaceuticals, and over-the-counter medications supplied to public health agencies and state government facilities. State and local governments procure these products through county health departments, state cooperative purchasing alliances, and multi-jurisdictional purchasing consortia. The work involves manufacturing and distribution of FDA-compliant pharmaceutical products meeting cGMP and Drug Supply Chain Security Act (DSCSA) requirements, with vendors typically required to maintain contractual relationships with authorized pharmaceutical wholesalers and demonstrate pricing flexibility across multiple net-price and WAC-minus formats.

Geographic activity includes Florida and Minnesota with multi-state reach through cooperative purchasing vehicles. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Minnesota Department of Administration's Office of State Procurement, on behalf of the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities including Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The MMCAP procurement weights pricing competitiveness at 75 percent of evaluation and requires vendors to pay a 3 percent administrative fee on all contract purchases.